Researchers have described for the first time the mechanism that gives a mutant enzyme molecule that they have engineered — and patented — the potential to become a breakthrough drug for treating heart attacks and strokes.
Researchers have described for the first time the mechanism that gives a mutant enzyme molecule that they have engineered — and patented — the potential to become a breakthrough drug for treating heart attacks and strokes.